This guideline supersedes Guideline UST-24 version 7 with the effect from 20 July 2021.
The Guideline is published with regard to and in compliance with the provision of Section 112 of Act No 378/2007 Coll., Section 27 of Act No 296/2008 Coll., Section 95 of Act No 268/2014 Coll. and Section 67 of Act No 89/2021 Coll.
The guideline is of the nature of a recommendation.
Annex 1 - Application for waiver/refund of reimbursement of costs pursuant to the Act on Pharmaceuticals and the Act on Human Tissues and Cells
Annex 2 - Application for refund of reimbursement of costs pursuant to the Act on Medical Devices an Act on In Vitro Diagnostic Medical Devices